NASDAQ:BCACU Brookline Capital Acquisition (BCACU) Stock Price, News & Analysis → I’m afraid WWIII is a very real possibility (From Porter & Company) (Ad) Free BCACU Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.09▼$23.2050-Day Range$9.04▼$23.2052-Week Range$8.40▼$23.20Volume9,829 shsAverage Volume3,706 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Brookline Capital Acquisition alerts: Email Address Ad True Market InsidersMy #1 investment for 2024It’s something you use every single day and don’t even know it.Click here to see my #1 investment for 2024. About Brookline Capital Acquisition Stock (NASDAQ:BCACU)Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.Read More Ad True Market InsidersMy #1 investment for 2024It’s something you use every single day and don’t even know it.Click here to see my #1 investment for 2024. BCACU Stock News HeadlinesSeptember 28, 2023 | investing.comChavant Capital Acquisition Corp (CLAY)September 26, 2023 | bizjournals.comBlackSand Capital funds loan for Discovery Bay AOAO acquisitionAugust 27, 2023 | finance.yahoo.comRevelstone Capital Acquisition Corp. (NASDAQ:RCAC) is definitely on the radar of institutional investors who own 30% of the companyAugust 26, 2023 | msn.comBrookline Bancorp: The Positives Outweigh The NegativesJuly 6, 2023 | health.usnews.comDr. Julian LenderOctober 15, 2022 | usnews.comThe Public Schools of BrooklineJune 6, 2022 | finance.yahoo.comApexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with ChemotherapyMay 24, 2022 | marketwatch.comBrookline Bancorp to Buy PCSB Financial for $313 MillionMarch 18, 2022 | finance.yahoo.comApexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology CompanyAugust 25, 2021 | barrons.comBrookline Capital Acquisition Corp. UnSee More Headlines Receive BCACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Shell Companies Sub-IndustryN/A Current SymbolNASDAQ:BCACU CUSIPN/A CIK1697805 Webwww.brooklinecapitalacquisitioncorp.com Phone646 643 6716FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Samuel P. Wertheimer Ph.D.Chairman & CEOMr. Scott A. Katzmann (Age 66)Pres & Director Mr. Patrick SturgeonChief Financial OfficerKey CompetitorsOmniLit AcquisitionNASDAQ:OLITWPerception Capital Corp. IINASDAQ:PCCTWVahanna Tech Edge Acquisition INASDAQ:VHNAWabrdn National Municipal Income FundNYSE:VFLAGM GroupNASDAQ:AGMHView All Competitors BCACU Stock Analysis - Frequently Asked Questions When did Brookline Capital Acquisition IPO? Brookline Capital Acquisition (BCACU) raised $50 million in an initial public offering on Friday, January 29th 2021. The company issued 5,000,000 shares at $10.00 per share. Ladenburg Thalmann acted as the underwriter for the IPO. This page (NASDAQ:BCACU) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brookline Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
